Andreas G. Moraitis

Andreas G. Moraitis currently serves as the Senior Vice President of Clinical Development at MBX Biosciences, Inc., focusing on advancing canvuparatide to meet significant patient needs since June 2025. Prior to this role, Andreas held various positions at Corcept Therapeutics from June 2014 to June 2025, including Senior Medical Director, Medical Director, and Associate Medical Director, with a focus on drug research and development. Earlier experience includes serving as an Assistant Professor in Endocrine Oncology at the University of Michigan Medical School from October 2012 to June 2014. Andreas completed a fellowship in Adult and Reproductive Endocrinology at the National Institutes of Health from 2010 to 2012 and earned a Doctor of Medicine (MD) from Ethnikon kai Kapodistriakon Panepistimion Athinon with a specialization in adrenal tumors, endocrine hypertension, and Cushing's syndrome.